KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Royalty Pharma (RPRX) over the last 5 years, with Sep 2025 value amounting to 0.12.

  • Royalty Pharma's Asset Utilization Ratio fell 1.73% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 1.73%. This contributed to the annual value of 0.13 for FY2024, which is 7.78% down from last year.
  • As of Q3 2025, Royalty Pharma's Asset Utilization Ratio stood at 0.12, which was down 2.77% from 0.13 recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Asset Utilization Ratio ranged from a high of 0.15 in Q4 2023 and a low of 0.12 during Q3 2025.
  • Its 3-year average for Asset Utilization Ratio is 0.13, with a median of 0.13 in 2024.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first climbed by 12.59% in 2023, then declined by 14.54% in 2024.
  • Quarterly analysis of 5 years shows Royalty Pharma's Asset Utilization Ratio stood at 0.13 in 2021, then dropped by 0.12% to 0.13 in 2022, then rose by 12.59% to 0.15 in 2023, then fell by 14.54% to 0.12 in 2024, then decreased by 1.73% to 0.12 in 2025.
  • Its Asset Utilization Ratio stands at 0.12 for Q3 2025, versus 0.13 for Q2 2025 and 0.13 for Q1 2025.